XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment Reporting SEGMENT REPORTING
Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”), or decision making group, whose function is to allocate resources to and assess the performance of the operating segments. The Company has identified its President and Chief Executive Officer as the CODM. In determining its reportable segments, the Company considered the markets and types of customers served and the products or services provided in those markets. The Company has determined that it has one operating segment and, therefore, one reportable segment.
Revenue by geographic regions are based upon the customers’ ship-to address for product revenue, the region of testing for testing services revenue and the region where the performance obligation is satisfied for patient and digital solutions revenue. The following table summarizes reportable revenue by geographic regions (in thousands):
Three Months Ended March 31,
20252024
Testing services revenue
United States$61,438 $53,650 
Rest of World483 187 
$61,921 $53,837 
Product revenue
United States$6,507 $5,276 
Rest of World4,303 3,318 
$10,810 $8,594 
Patient and digital solutions revenue
United States$11,920 $9,584 
Rest of World34 34 
$11,954 $9,618 
Total revenue
Total United States$79,865 $68,510 
Total Rest of World4,820 3,539 

$84,685 $72,049 
The following table summarizes long-lived assets, consisting of property and equipment, net, by geographic regions (in thousands):
March 31, 2025December 31, 2024
Long-lived assets:
United States$32,450 $33,286 
Rest of World279 266 
Total$32,729 $33,552 
The Company's CODM assessed the Company’s performance by using net loss. The CODM uses net loss predominately in the annual budget and forecasting process. The CODM considers budget-to-actual variances on a quarterly basis for the profit measure when making decisions. The CODM organizes the business and leaders functionally. The CODM assesses performance and resources are allocated to functions which utilize those allocations across the business's services, products and digital solutions offerings.
The following table summarizes the reconciliation to net loss (in thousands):
Three Months Ended March 31,
20252024
Revenue:
Testing services revenue
$61,921 $53,837 
Product revenue
10,810 8,594 
Patient and digital revenue
11,954 9,618 
Total revenue
84,685 72,049 
Less:
Cost of testing services1
14,403 12,846 
Cost of product1
4,943 4,607 
Cost of patient and digital solutions
7,344 6,315 
Personnel cost
30,743 26,528 
Professional and legal fees
10,192 12,173 
Research materials and clinical trials expense
3,174 3,480 
Depreciation and amortization expense
2,950 3,378 
Stock-based compensation expense
8,931 16,573 
Litigation settlement expense
5,360 — 
Other segment items2
9,781 8,923 
Interest income, net
(2,783)(2,886)
Segment and condensed consolidated net loss
$(10,353)$(19,888)
1 Cost of testing services and cost of product include depreciation expense
2 Other segment items include the following: acquisition costs, software expenses, corporate expenses, rent and maintenance expense, travel and event related expense, and other expenses (income)